Company K Partners

Funding rounds backed by Company K Partners.

Export CSV
Funding disclosed in full
$149M
Median round
$74.5M
Rounds in calculation
2
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
KaliVir Immunotherapeutics

Develops oncolytic immunotherapies for patients with advanced solid tumors

$14MSeries ABiotechUnited States
5 participantsCompany K PartnersFlexus PartnersNextransQuad Investment ManagementSV Investment
XCENA

Builds CXL computational memory chips and SDK for AI infrastructure in hyperscalers, telcos, and research

$135MSeries BAIUnited States
22 participantsAtinum InvestmentCompany K PartnersCorstone AsiaDSC InvestmentIMM InvestmentK2 Investment PartnersKDB CapitalKiwoom InvestmentKolon InvestmentKorea Development BankKyobo LifeKyobo SecuritiesLB InvestmentMirae Asset CapitalMirae Asset Venture InvestmentsPartners InvestmentPremier PartnersSBI InvestmentShinhan Venture InvestmentSTIC VenturesSV InvestmentWonik Investment Partners